INTRODUCTION
In 1979, Galanos and colleagues established an elegant model for endotoxin shock by increasing the sensitivity of rabbits, rats and mice to the lethal action of LPS many thousand-fold by treatment with D-galactosamine (GalN). Sensitization by GalN could be reversed by uridine, which inhibits the biochemical metabolism in hepatocytes. 1 Hypersensitivity to the lethal effects of LPS caused by the treatment with GalN could be transferred to LPS-resistant C3H/HeJ mice by injection of bone marrow macrophages from C3H/HeN mice 2 and replaced by injection of TNF-a, one of the pro-inflammatory cytokines primarily produced by LPS-elicited macrophages. 3, 4 Administration of killed Gram-positive bacteria such as Staphylococcus aureus, Propionibacterium acnes, Mycobacterium phlei 5 and their DNA or certain oligonucleotides displaying unmethylated CpG-motifs exhibited similar toxicity in GalN-sensitized mice. 6 Toxoplasma gondii also triggered granulocytedependent cytokine-mediated lethal shock due to up-regulation of plasma TNF-a levels in GalN-sensitized mice. 7 The superantigen staphylococcal enterotoxin B caused lethal shock via T-cell-mediated TNF-a production in GalN-sensitized mice. 8 Pretreatment with a recombinant protein of soluble TNF receptor fused to a part of human IgG fully protected from the lethal effects of LPS. 9 These results show that treatment with GalN renders mice hypersensitive to TNF-a, produced by macrophages and other cells stimulated with components from Gram-negative and Gram-positive bacteria, and that TNF-a is a common endogenous mediator of the lethal activity in this model. Several groups have demonstrated that the mechanisms by which TNF-a causes lethal shock involve activation of apoptosis in hepatocytes. [10] [11] [12] This model, in which TNF-a is the main pathogenic factor and induces apoptosis of hepatocytes followed by liver dysfunction, has been The role of high mobility group-1 protein (HMG-1) in LPS-and TNF-a-induced lethal shock in galactosamine (GalN)-sensitized mice was investigated. No detectable HMG-1 levels were observed by immunoblotting analysis in plasma from untreated or GalN-sensitized BALB/c mice 5 h after LPS injection, although significant levels of HMG-1 were detected in plasma 6 h after the challenge. All GalN-sensitized BALB/c but not BALB/lps d mice succumbed by 6 h after LPS injection. When GalN-sensitized mice were injected with TNF-a, the presence of HMG-1 was seen at 5.5 h in plasma of BALB/c mice and at 6 h in BALB/lps d mice, although almost all GalNsensitized BALB/c mice died by 6 h after challenge. The time-dependent phenomenon correlated with elevated serum aspartate aminotransferase (AST) levels and the appearance of apoptotic cells in livers. Administration of pooled plasma, equivalent to approximately 200 mg recombinant murine HMG-1, taken from mice on the verge of near death, did not result in induction of lethal shock in GalN-sensitized mice. Taken together with the late appearance of HMG-1 in moribund mice, these data suggest that HMG-1 does not decisively contribute to lethality in the GalN sensitization model. widely used for investigation of endotoxin shock, although recent results show that the consequences of endotoxic shock and the results of liver failure mediated by TNF-a should be separated. 13 High-mobility group-1 protein (HMG-1) is ubiquitously expressed as a DNA-binding protein to stabilize nucleosome formation, to facilitate gene transcription, and to regulate the activity of steroid hormone receptors. Recently, Wang et al. 14 and Andersson et al. 15 demonstrated that HMG-1 is a late mediator of LPS lethality, because: (i) the exposure of cultured macrophages to LPS and TNF released HMG-1 from 8 h onwards; (ii) stimulation of human monocytes with HMG-1 resulted in synthesis of cytokines such as TNF, IL-1, IL-1RA, IL-6, etc.; and (iii) administration of HMG-1 to mice significantly increased serum TNF levels in vivo and was lethal. Serum concentrations of HMG-1 were increased during an episode of hemorrhagic shock in a patient who had undergone repair of an abdominal aortic aneurysm. 16 Septic patients who succumbed to infection had increased serum HMG-1 levels, suggesting that HMG-1 may be involved in the pathogenesis of septic shock and warrants investigation as a therapeutic target. These findings stimulated us to investigate the relationship of HMG-1 as a late mediator, and TNF-a as an early mediator, for LPS lethality in GalN-sensitized mice.
MATERIALS AND METHODS

Chemicals
Heparin (1000 units/ml, Novo Nordisk A/S, Denmark), D-galactosamine-HCl (GalN; Wako Pure Chemical Co., Osaka, Japan), recombinant murine TNF-a (PeproTech EC Ltd, London, UK) and highly purified LPS preparation from Salmonella abortus equi, a gift from Dr Chris Galanos (Max-Planck-Institute for Immunobiology, Freiburg in Breisgau, Germany) were diluted with or dissolved in sterile saline (Ohtsuka Pharmaceutical Co., Tokushima, Japan).
Animals
Breeding pairs of BALB/c and LPS-resistant BALB/lps d mice were obtained from the Jackson Laboratories (Bar Harbor, ME, USA) and the Max-Planck-Institute for Immunobiology, respectively. Mice of both sexes raised in the animal facility of the School of Science, Kitasato University, under specific-pathogen-free conditions were used at 10-14 weeks of age. The experiments described in this article were performed in adherence to the guidelines of the National Institutes of Health on the use of experimental animals. Approval of the Animal Use Committee of the Kitasato University School of Science was obtained prior to initiating the experiments.
Administration of LPS or TNF-a and sensitization with GalN
Mice were injected intraperitoneally with 20 mg GalN in a volume of 0.5 ml immediately after intravenous injection with either 100 ng of S. abortus equi LPS or 1 mg of TNF-a in a volume of 0.2 ml.
Preparation of plasma
Following deep anesthesia with diethyl ether, blood was taken from mice by cardiac puncture using a 1-ml syringe, immediately mixed well with 20 ml heparin and then centrifuged at 7200 g for 1 min at room temperature. Plasma samples were collected carefully to avoid contamination by platelets and maintained at -80°C until use.
Determination of endotoxin units (EU)
The content of LPS in test samples was analyzed by determining the EU value by a method described previously. 17, 18 
Determination of survival time
From 5 h after injections, behaviors such as squatting down, no recovery from turning up faces and changing eyecolor, signs of imminent death, were carefully watched. Death in mice displaying these signs occurred subsequently within a couple of minutes, thus confirming the previous diagnosis of imminent death. The time point when mice showed these signs was judged as the survival time. Blood was taken immediately.
Preparation of recombinant HMG-1
A purified plasmid pHMG/NCH3 (1 mg) was used for transformation of Bacillus brevis using a Gene Pulser (Bio-Rad Laboratories, Hercules, CA, USA) under conditions of 1.5 kV, 1000 N and 25 mF. Transformed cells were incubated on MT-agar plates containing neomycin for 2 days. After confirming the insertion of pHMG/NCH3, transformed B. brevis cells were incubated in TM broth for 3 days to secrete a histidine-tagged recombinant HMG-1 (rHMG-1). The rHMG-1 was separated from culture fluids by passing through a Nicolumn. This preparation stimulated murine macrophages to produce TNF-a at a concentration of 1 mg and could be detected by immunoblotting analysis.
Preparation of liver homogenates
Livers were removed at different time points after perfusion with Hanks' balanced salt solution. Livers were suspended in 20-fold (v/w) excess of an extract solution consisting of 5 M urea, 1 M thiourea, 0.5% 2-mercaptoethanol and Complete-Mini-EDTA-free (protease inhibitor cocktail, Roche, Mannheim, Germany) and stroked 15 times using a Potter type-homogenizer. Homogenates were centrifuged at 75,000 g for 40 min at 4°C and the supernatants were assayed.
Determination of aspartate aminotransferase (AST)
Serum was prepared from blood taken by cardiac puncture at the indicated time. After standing for 60 min at room temperature, serum fractions were further centrifuged at 700 g for 5 min, and clear supernatants were collected. Serum AST levels were determined using a Bio Majesty analyzer (JEOL Ltd, Tokyo, Japan) after mixing test sera with the AST-JS reagent (Shino-Test Corp., Tokyo, Japan) according to the protocols of the manufacturer. Data are expressed arithmetic mean -SD in international units (IU) per liter.
Electrophoresis and immunoblotting
Plasma samples were mixed with sample buffer, heated in boiling water for 2 min and analyzed using a 12.5% gel by SDS-PAGE. For immunoblotting, the plasma HMG-1 level was visualized using affinity-purified rabbit anti-HMG-1 polyclonal antibody (BD PharMingen, San Diego, CA, USA) and a VECTASTAIN ABC-PO kit (Vector Laboratories Inc., Burlingam, CA, USA).
Determination of lethal activity of plasma HMG-1 in GalN-sensitized mice
To estimate lethal activity of plasma HMG-1, BALB/lps d mice were treated twice with 20 mg GalN, 0 and 5 h after intravenous injection, with 0.5 ml of plasma samples. A pooled plasma sample was taken from GalNsensitized BALB/c mice 5.5 h after 100 ng LPS injection. A control plasma sample with undetectable HMG-1 levels was prepared from GalN-sensitized BALB/c mice 5 h after LPS injection.
Histochemical analysis
For histochemical analysis, livers were removed from untreated control, LPS-treated and TNF-a-treated mice, fixed with 4% paraformaldehyde in 0.01 M phosphate buffer (pH 7.4) and embedded in paraffin. Sections were stained with hematoxylin and eosin (HE).
Detection of apoptotic cells in liver
Apoptotic cells were detected by the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method using an in situ apoptosis detection kit (MK503; Takara Shuzo Co. Ltd, Kyoto, Japan). Staining of liver sections was performed according to the manufacturer's recommendations. Briefly, sections were deparaffinized and then treated with proteinase K (20 mg/ml) in PBS. Endogenous peroxidase was blocked by a subsequent incubation with 3% H 2 O 2 in methanol for 15 min. After washing with PBS, TUNEL reaction mixture was dropped on slides and incubated for 90 min at 37°C. Apoptotic cells were then detected with horseradish peroxidase-conjugated anti-FITC antibodies and 0.26 mg/ml diaminobenzidine (Sigma) followed by counterstaining with 1% methylgreen.
Statistical analysis
Statistical significance of the data was determined by the Student's t-test. A P value of less than 0.05 was taken as significant.
RESULTS
Time-dependent release of HMG-1 into plasma after injection of LPS into GalN-sensitized mice
Wang and colleagues showed that serum levels of HMG-1 increased from 8 h after stimulation with LPS and TNFa, 14 and we confirmed that no detectable levels of plasma Does HMG-1 function as a late mediator for shock in GalN-sensitized mice? 393 HMG-1 were found in normal mice, although HMG-1 could be detected in supernatants of liver homogenates by Western blotting (Fig. 1) . When BALB/c mice were injected intravenously with 100 ng of S. abortus equi LPS and intraperitoneally with GalN, all BALB/c but not BALB/lps d mice succumbed approximately 6 h after injection. No detectable levels of HMG-1 were found in plasma of BALB/c mice 0 h, 4 h and 5 h after LPS injection ( Figs  1 & 2A) , while a clear band of HMG-1 was observed in plasma of BALB/c mice only 6 h after injection ( Fig. 2A) . On the other hand, no detectable levels of plasma HMG-1 in LPS-resistant BALB/lps d mice were found even at 6 h.
Time dependency of HMG-1 release after TNF-a injection into GalN-sensitized mice
When GalN-sensitized mice were injected intravenously with 1 mg murine TNF-a, quicker and higher responses in terms of HMG-1 release than in LPS-injected BALB/c mice were observed in both BALB/c and BALB/lps d mice.
In particular, higher levels of plasma HMG-1 could be detected in BALB/c mice from 5 h after challenge with TNF-a. At this time point, death of almost all animals would subsequently occur within 30 min (data not shown). Levels of plasma HMG-1 in BALB/c mice 6 h after LPS injection were comparable to those in BALB/c mice 5.5 h after TNF-a administration. In BALB/lps d mice, HMG-1 could also be detected 6 h after TNF-a injection ( Fig. 2A) . Almost all animals showed lethal shock at this time point. Taken together, the release of HMG-1 into the circulation is time-dependent and detectable at time points near to life termination (Figs 1 & 2A) .
No induction of lethal shock by administration of plasma containing HMG-1
A pooled plasma sample, taken from GalN-sensitized BALB/c mice 5.5 h after LPS injection, contained approximately 200 mg HMG-1 in 0.5 ml, calculated from immunoblotting analysis using recombinant HMG-1 (Fig. 2B) . To estimate whether a test sample containing HMG-1 (0.5 ml) causes lethal shock in GalN-sensitized mice and to avoid the effect of potentially contaminating LPS, BALB/lps d mice were injected with plasma samples (0.5 ml) and twice with GalN at 0 h and 5 h. Neither plasma containing HMG-1 (equivalent to 200 mg) nor control plasma induced lethal shock in these mice.
Histochemical analysis of livers
Liver damage induced in GalN-sensitized mice by injections with LPS or TNF-a was preceded by typical events of apoptosis, i.e. chromatin condensation, DNA fragmentation and formation of intracellular apoptotic bodies. 10 At 5 h after injection with LPS ( Fig. 3B) , partial congestion and hepatocyte apoptosis began in livers of GalN-sensitized mice compared with untreated controls (Fig. 3E) . A somewhat higher incidence of TNF-a-induced apoptosis than in LPS-injected mice was observed in hepatocytes 394 Hasunuma, Maruyama, Takimoto, Ryll, Tanaka, Kumazawa after 5 h (Fig. 3A,B) . Dramatic changes became observable in the histology of livers 5.5 h after a challenge with TNF-a ( Fig. 3C ) or 6 h after administration of LPS (Fig.  3D) . The presence of many apoptotic cells and induction of hemorrhage in livers were demonstrated histochemically. The TUNEL method (Fig. 3G ) confirmed a large number of apoptotic cells in a liver section suggested by HE staining in Figure 3A in one of the GalN-sensitized mice 5 h after TNF-a injection, while apoptotic cells were absent in an untreated control (Fig. 3F) . These results indicate that increase in numbers of apoptotic hepatocytes correlates well with the time point when detectable levels of HMG-1 release are found in plasma.
Serum AST levels
Increased serum levels of AST generally reflect necrosis or apoptosis in hepatocytes. When we measured serum AST levels in GalN-sensitized BALB/c mice ( Fig. 4) , quite low levels, near to those of untreated controls and of LPS-resistant BALB/lps d mice, were observed 5 h after LPS challenge. Serum AST levels then markedly increased in BALB/c mice 6 h after the challenge, following a profile similar to HMG-1 appearance. A significant difference was observed in AST levels of BALB/c mice between 5-6 h after LPS injection (P < 0.001).
Significant increases in plasma AST levels, comparable to those of HMG-1 release, were observed in GalN-sensitized BALB/c and BALB/lps d mice after administration of TNF-a (P < 0.05 and P < 0.01, respectively). In addition, BALB/c mice showed significantly higher responses than BALB/lps d mice at 5 h after TNF-a injection (P < 0.01).
DISCUSSION
The present study clearly showed that, after injection with either LPS or TNF-a, release of HMG-1 into the circulation of GalN-sensitized mice occurred in a timedependent manner ( Fig. 2A ). Significant levels of plasma HMG-1 appeared to correlate to a time-dependent increase in serum AST levels after the induction of massive apoptosis in hepatocytes (Figs 2A, 3 & 4) . It should be noted that the source of HMG-1 was actually not positively identified in our experiments.
Generally, treatment with GalN renders mice hypersensitive to LPS as well as TNF-a, produced by macrophages and other cells stimulated with Gram-negative and Gram-positive bacteria and their components. [2] [3] [4] [5] [6] [7] [8] [9] In the GalN-sensitization model, TNF-a is the main pathogenic factor for causing lethal shock and the mechanisms by which TNF-a induces lethal shock are due to the activation of apoptosis of hepatocytes. [10] [11] [12] [13] Since Wang et al. 14 and Andersson et al. 15 recently showed that HMG-1 is a late mediator of LPS lethality, we monitored the release of HMG-1 into the circulation of GalN-sensitized mice by Western blotting. The release of HMG-1 was observed at detectable levels 5 h after TNF-a injection, although in LPS-injected mice it was not yet observed at this time point ( Fig. 2A) . A clear band of HMG-1 was detected in plasma of these mice 6 h after LPS injection ( Fig. 2A) .
Simultaneous injection with endotoxin-free TNF-a and nanogram quantities of LPS caused hemorrhagic necrosis and lethal shock in normal mice by their synergistic effects. 19 The TNF-a preparation in our experiments was found to be contaminated by LPS at a concentration of 0.02 EU/mg, equivalent to approximately 2 pg of a purified LPS preparation from S. abortus equi. 17 In LPS-nonresponder BALB/lps d mice, plasma HMG-1 levels caused by TNF-a administration were lower than those in BALB/c mice ( Fig. 2A) . The responsiveness of BALB/lps d mice to TNF-a should be identical to that of BALB/c mice, since BALB/lps d mice share the same genetic background as BALB/c mice except for their unresponsiveness to LPS. 20, 21 Therefore, lower responsiveness of BALB/lps d mice in terms of HMG-1 release would represent the response exclusively to TNF-a, without any influence of potentially contaminating LPS traces in the TNF-a preparation. Conversely, a higher HMG-1 release in BALB/c mice would reflect the synergistic action of contaminating LPS and TNF-a.
Leist et al. 10 showed that injections with LPS and TNF-a caused typical signs of apoptosis (i.e. chromatin condensation, DNA fragmentation and formation of intracellular apoptotic bodies) in hepatocytes of mice treated with transcriptional inhibitors such as GalN and actinomycin D, and that DNA was cleaved into oligonucleosomal fragments in hepatocytes before a significant increase in plasma levels of liver enzyme alanine aminotransferase (ALT) as well as sorbitol dehydrogenase (SDH) and AST occurred. In a previous study, we demonstrated by TUNEL staining that apoptosis was induced in livers of GalN-sensitized mice after LPS challenge. 22 Histochemical analyses using HE and TUNEL staining revealed that the partial congestion in livers and hepatocyte apoptosis started in GalN-sensitized mice 5 h after injection with LPS ( Fig. 3 ), although quite low levels of serum AST, near to those of untreated controls and of LPS-resistant BALB/lps d mice, were observed 5 h after LPS injection (Fig. 4) . Serum AST levels were significantly different between 5 h and 6 h after LPS injection. The time-dependent increase in serum AST levels in our present study was similar to that of plasma levels of three liver enzymes (ALT, SDH and AST) in GalN-sensitized mice 5 h and 8 h after LPS injection in the study of Leist et al., 10 although there was a minor delay due to different experimental conditions, suggesting that an increase in serum AST levels appears to occur after the induction of apoptosis of hepatocytes.
The possibility that TNF-a could be triggered by the production of HMG-1 from macrophages and that HMG-1 acts as a late mediator has been suggested. 14, 15 At 5 h after LPS injection, however, detectable levels of plasma HMG-l were not yet observed ( Fig. 2A) , although partial congestion and apoptosis in livers of GalN-sensitized BALB/c mice had started (Fig. 3E ). This indicates that hepatocytes have already received sufficient signals to induce apoptosis at 5 h without the contribution of HMG-1. The answer would be suggested by our observation that plasma from moribund mice with high levels of HMG-1 was not sufficient to trigger shock after transfusion into GalN-sensitized BALB/lps d mice. It appears that, in the murine model system of GalN sensitization, the effects of TNF-a as an early cytokine rather than HMG-1 as a late cytokine are decisive for a lethal outcome, although additional experiments are certainly required to clarify this point further.
In conclusion, HMG-1 would not function as a late mediator for the lethal effects of LPS under the parameters of this GalN-sensitization model, because the primary action of TNF-a, produced by LPS-stimulated macrophages, is sufficient to cause liver failure without the secondary action of HMG-1.
It also should be noted that these results do not invalidate any HMG-1-related observations made in humans: GalN sensitization was developed to increase the comparatively low endotoxin sensitivity of mice in order to allow research ultimately helping human patients. Nevertheless, it appears that even after more than two decades, this elegant system devised by Chris Galanos and his co-workers is still able to answer important questions of endotoxin research.
